New Horizon Health Limited

SEHK:6606 Stock Report

Market Cap: HK$6.3b

New Horizon Health Future Growth

Future criteria checks 5/6

New Horizon Health is forecast to grow earnings and revenue by 60.4% and 20.5% per annum respectively. EPS is expected to grow by 60% per annum. Return on equity is forecast to be 19.5% in 3 years.

Key information

60.4%

Earnings growth rate

60.0%

EPS growth rate

Healthcare earnings growth19.0%
Revenue growth rate20.5%
Future return on equity19.5%
Analyst coverage

Low

Last updated12 Jun 2024

Recent future growth updates

Recent updates

New Horizon Health Limited (HKG:6606) Stocks Shoot Up 29% But Its P/S Still Looks Reasonable

Mar 04
New Horizon Health Limited (HKG:6606) Stocks Shoot Up 29% But Its P/S Still Looks Reasonable

Should You Investigate New Horizon Health Limited (HKG:6606) At HK$18.38?

Jan 30
Should You Investigate New Horizon Health Limited (HKG:6606) At HK$18.38?

Should You Think About Buying New Horizon Health Limited (HKG:6606) Now?

Sep 28
Should You Think About Buying New Horizon Health Limited (HKG:6606) Now?

New Horizon Health (HKG:6606) Is Posting Healthy Earnings, But It Is Not All Good News

Sep 28
New Horizon Health (HKG:6606) Is Posting Healthy Earnings, But It Is Not All Good News

Benign Growth For New Horizon Health Limited (HKG:6606) Underpins Stock's 26% Plummet

Aug 02
Benign Growth For New Horizon Health Limited (HKG:6606) Underpins Stock's 26% Plummet

New Forecasts: Here's What Analysts Think The Future Holds For New Horizon Health Limited (HKG:6606)

Jul 14
New Forecasts: Here's What Analysts Think The Future Holds For New Horizon Health Limited (HKG:6606)

News Flash: Analysts Just Made A Substantial Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Mar 19
News Flash: Analysts Just Made A Substantial Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their New Horizon Health Limited (HKG:6606) Revenue Forecasts By 26%

Jan 13
Growth Investors: Industry Analysts Just Upgraded Their New Horizon Health Limited (HKG:6606) Revenue Forecasts By 26%

News Flash: Analysts Just Made A Captivating Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Mar 23
News Flash: Analysts Just Made A Captivating Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts

Need To Know: Analysts Are Much More Bullish On New Horizon Health Limited (HKG:6606) Revenues

Jan 19
Need To Know: Analysts Are Much More Bullish On New Horizon Health Limited (HKG:6606) Revenues

Earnings and Revenue Growth Forecasts

SEHK:6606 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,732825309N/A1
12/31/20253,612546-60N/A3
12/31/20242,835266-383N/A3
12/31/20231,84310-235N/A3
6/30/20231,362112-630-521N/A
3/31/20231,06316-548-467N/A
12/31/2022765-79-466-413N/A
9/30/2022580-169-483-434N/A
6/30/2022394-259-500-455N/A
3/31/2022304-1,672-446-405N/A
12/31/2021213-3,085-392-355N/A
9/30/2021164-3,244-325-289N/A
6/30/2021104-3,128-243-210N/A
3/31/202187-1,958-199-171N/A
12/31/202071-789-156-132N/A
9/30/202058-578-159-138N/A
6/30/202056-645-104-77N/A
3/31/202057-375-106-76N/A
12/31/201958-106-109-75N/A
12/31/201819-225-73-56N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6606's forecast earnings growth (60.4% per year) is above the savings rate (2.2%).

Earnings vs Market: 6606's earnings (60.4% per year) are forecast to grow faster than the Hong Kong market (11.7% per year).

High Growth Earnings: 6606's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 6606's revenue (20.5% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 6606's revenue (20.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6606's Return on Equity is forecast to be low in 3 years time (19.5%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.